Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study [Clinical Sciences]

Conclusions— An improvement of OAC use among Chinese patients with AF in Beijing is observed in recent years although only 36.5% of patients with CHA2DS2-VASc score ≥2 received OAC. However, variations between different hospitals were large, suggesting that better education and awareness are needed to improve efforts for stroke prevention among AF patients. Clinical Trial Registration— URL: http://www.chictr.org.cn/showproj.aspx?proj=5831. Unique identifier: ChiCTR-OCH-13003729.

http://stroke.ahajournals.org/cgi/content/short/47/7/1803?rss=1

Source: Stroke - June 26, 2016 Category: Neurology Authors: Chang, S.-S., Dong, J.-Z., Ma, C.-S., Du, X., Wu, J.-H., Tang, R.-B., Xia, S.-J., Guo, X.-Y., Yu, R.-H., Long, D.-Y., Bai, R., Liu, N., Sang, C.-H., Jiang, C.-X., Liu, X.-H., Pan, J.-H., Lip, G. Y. H. Tags: Atrial Fibrillation, Epidemiology, Anticoagulants Clinical Sciences Source Type: research